MedPage Today

FDA Greenlights Imaging Agent to Detect Residual Cancer After Lumpectomy

The FDA approved pegulicianine (LumiSight) as an optical imaging agent for detecting residual cancer after breast-conserving surgery (BCS). The approval stipulates use of pegulicianine with the ...
Business Wire

Lumicell’s Cutting-Edge Imaging Platform Receives Historic FDA Approval to Illuminate Residual Breast Cancer

NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, today ...
Southeast Missourian

New radiation treatment for post-lumpectomy patients is faster, easier

Breast cancer is hard enough. Treatment should be quick and easy. That's the thinking of many physicians who have opted to offer MammoSite, a type of radiation that cuts treatment time from several ...
Business Insider

Single-Dose Radiation Therapy At Time Of Lumpectomy Helps Breast Cancer Patients Overcome Treatment Challenges During Pandemic

SACRAMENTO, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- The TARGIT Collaborative Group announced today that according to recent studies, an increase in the COVID-19 positivity rate correlates to an ...
ascopubs.org

Assessing the marginal costs of radiation therapy and antiestrogen therapy for post-lumpectomy, early-stage breast cancer across Medicaid and Medicare plans.

Differential benefit of capecitabine-based chemotherapy among TNBC subtypes in the context of the CBCSG010 study. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract ...
WebMD

Mastectomy vs. Lumpectomy

A breast cancer diagnosis usually brings up many feelings at once. Getting the facts you need to choose the best treatment plan can help you feel more in control. If surgery is an option for you, one ...